Total Funding
78
65
Total FundingPost-IPO Equity raised
Growth Score 78 in past quarter
-17 pts
Heat Score 65 in past quarter
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
40657
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
- Peter Thompson: Co-Founder and DirectorPast Role: Terremoto Biosciences, CEO and Co-Founder
- Leiv Lea: CFO
About the Company
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. With accomplished and talented scientists, and top-tier investors, we are well positioned in an exciting new era of immuno-oncology.
